MB Therapeutics Archives

Home Tags MB Therapeutics

MB Therapeutics secures €2 million to accelerate the go-to-market strategy of 3D printed drugs

(3DA) - February 25, 2025

Established in 2022, MB Therapeutics is the latest company to join the pharmaceutical 3D printing market. The company turns stealth mode off with a...

About

Published by KEYMAR Solutions, 3D ADEPT Media is a trade press that tracks and analyses the latest trends in the additive manufacturing industry. As a source for high-quality, accurate, and timely additive manufacturing resources, we pride ourselves on delivering up-to-date information you can rely on through our online media and our print & interactive digital magazine 3D ADEPT Mag.

We love to think that this industry delivers “glocalized” manufacturing solutions to industries (in a nutshell, solutions that are both global and local). That is why we work with collaborators and partners across the world so that industries can easily identify the manufacturing path that best fits their needs. Learn more

CONTACT US : 3D ADEPT MEDIA by KEYMAR SOLUTIONS SRL – VAT: BE0681.599.796
Rue Borrens 51 – 1050 Brussels
Email: contact@3dadept.com
Tel: +32(0)486745887

MB Therapeutics secures €2 million to accelerate the go-to-market strategy of 3D printed drugs

Osteopore’s 3D printed implants are added to Singapore’s Ministry of Health’s subsidy list

NASA tests a 3D-printed antenna to demonstrate a low-cost capability to communicate science data to Earth

Ourobionics unveils a 5-in-1 solution to address problems in multiple cell-based biomanufacturing industries

MB Therapeutics secures €2 million to accelerate the go-to-market strategy of 3D printed drugs

Osteopore’s 3D printed implants are added to Singapore’s Ministry of Health’s subsidy list

NASA tests a 3D-printed antenna to demonstrate a low-cost capability to communicate science data to Earth

Apiar introduces a collection of metal 3D printed watches

Differences in the pace of AM adoption across regions: The Lithoz case

What are the key performance indicators for a good (metal) AM production?

Lessons from the AM industry’s frontlines

Startup Area | 10 Additive Manufacturing companies that turned stealth mode off in 2024

AM Shapers | Behind the scenes of Ford’s AM journey in Europe

Q&A | BMF on the current state of the micro 3D printing market and where it is headed for

Differences in the pace of AM adoption across regions: The Lithoz case

Lessons from the AM industry’s frontlines

FOCUS | How Evonik’s use of LCA helps deliver a strong sustainable INFINAM eCO line for the AM industry

Formnext Awards 2024: Who are the winners?

FOCUS | Moving toward industrialization with 3DCeram’s Ceramic 3D printing

ECKART TLS broadens its metal powder portfolio for Additive Manufacturing

Thermwood to conduct a live demo of its LSAM Additive Printer 510 at JEC World 2025

9th Military Additive Manufacturing Summit & Technology Showcase: Registration & Agenda

JEC World 2025: Celebrating 60 years of innovation under the Motto “Pushing the Limits”

Formnext Awards 2024: Who are the winners?

Tag: MB Therapeutics

MB Therapeutics secures €2 million to accelerate the go-to-market strategy of 3D printed drugs